AI blood check could spot silent killers years before symptoms
NCT ID NCT07570667
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find early signs of diseases like heart disease, diabetes, and cancer by analyzing blood samples over time. Researchers will collect health data and blood from 15,000 adults aged 40-70 to create personalized health baselines using artificial intelligence. The goal is to develop a screening tool that can detect disease before symptoms appear, allowing for earlier and more personalized care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
School of Public Health, The University of Hong Kong
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Squeeze away hypertension? handgrip device put to the test
- Blood pressure cuffs and health classes: a new approach to close a heart health gap
- AI tailors lifestyle tips to tackle high blood pressure
- Personality type may influence diabetic wound healing – a study investigates
- Could a simple clinic Check-In change catch hidden high blood pressure and diabetes?
- Can a strong support network help people with diabetic kidney disease take better care of themselves?